Canopy Growth Corporation · TSX:WEED

Canopy Growth — Q1 FY2023 Earnings Presentation

22 slides from Canopy Growth's earnings presentation, Aug 5, 2022

  1. Slide 1: Q1 FY2023 Earnings Presentation

    CANOPY GROWTH Q1 FY2023 EARNINGS PRESENTATION August 5, 2022

  2. Slide 2: Disclaimers and Cautionary Statements

    DISCLAIMERS AND CAUTIONARY STATEMENTS This presentation contains “forward-looking statements” and “forward-looking information” within the meaning of applicable U.S. and Canadian securities laws (collectively, “forward -looking statements ”) which involve certain known and unknown risks and uncertai

  3. Slide 3: Non-GAAP Measures

    NON-GAAP MEASURES Adjusted EBITDA is a non-GAAP measure used by management that is not defined by U.S. GAAP and may not be comparable to similar measures presented by other companies. Adjusted EBITDA is calculated as the reported net income (loss), adjusted to exclude income tax recovery (expense);

  4. Slide 4: Today's Speakers

    TODAY’S SPEAKERS DAV ID KLEIN J UDY HONG CEO CFO 4

  5. Slide 5: Agenda

    AGENDA • Key Takeaways • Progress Against Key Priorities • Q1 FY2023 Financial Results Review • Q&A • Unless otherwise indicated, all financial information in this presentation is reported in Canadian dollars. • Unless otherwise indicated, market share data disclosed in this press release is calcula

  6. Slide 6: Key Takeaways

    KEY TAKEAWAYS Strong brand performance and innovation are helping stabilize market share in core segments of the Canadian adult-use market • Company maintained #1 share of combined premium flower and pre-roll segment in Q1 FY2023 1, led by in demand offerings from Doja and 7ACRES including new 7ACRE

  7. Slide 7: Progress against Premiumization strategy

    Progress against Premiumization strategy • New premium flower SKUS in Q1 FY23 under the Doja brand • New premium flower SKUS shipped under the 7ACRES brand included OG Deluxe and Fresh Biscotti in Q1 FY2023 include Lemon Zkitz, Platinum Kush Breath and Grape Gelena. • Doja OG Deluxe and Cold Creek K

  8. Slide 8: Progress against Premiumization strategy

    Progress against Premiumization strategy • New The Grape Unknown and Ginger Ale Galaxy shipped in Q1 • Launched a range of new Tweed branded flower strains including FY2023. Deep Space is #2 ranked brand in the over 5 mg THC Tiger Cake, Wedding Cake, Kush Mints and Black Triangle in beverage categor

  9. Slide 9: Record BioSteel Revenue in Q1 FY2023

    record BIOSTEEL revenue in Q1 FY2023 • BioSteel Q1 FY2023 revenue increased 167% versus the prior year driven by higher distribution of the brand’s RTD hydration drinks. • RTD ACV increased to over 21%in Q1 FY20232 up from 3% in Q1 FY2022 • Secured retail listing of RTD in 2,200 Walmart Stores acros

  10. Slide 10: Strengthening U.S. THC Ecosystem

    Strengthening U.S. THC Ecosystem INVESTING IN PLANS TO ACQUIRE LEADING COMPANIES, IN MUST-WIN CATEGORIES, WITH BRANDS THAT CAN SCALE ACROSS NORTH AMERICA ACREAGE HOLDINGS Wana Brands Acreage made solid progress in their Q1 Fiscal 22 (quarter ended Wana entered new markets–including Puerto Rico and A

  11. Slide 11: Q1 FY2023 Financial Results

    Q1 FY2023 FINANCIAL RESULTS 11

  12. Slide 12: Q1 FY2023 Key Financial Highlights

    Q1 FY2023 KEY FINANCIAL HIGHLIGHTS vs. • FY2022 Net Revenue decreased 19% due to declines (CDN in millions) Q1 FY2023 Q1 FY2022 Q1 FY2022 in our organic Canadian cannabis business and the Net Revenue $110 $136 (19)% divestiture of C 3. • Gross margin was negatively impacted by lower Adjusted Gross M

  13. Slide 13: Revenue Performance by Segment

    REVENUE PERFORMANCE BY SEGMENT vs. (in millions of Canadian dollars, unaudited ) Q1 FY2023 Q1 FY2022 Q1 FY2022 Canadian Recreational Cannabis Net Revenue Business to Business1 $26.6 $42.7 (38)% Business to Consumer $12.4 $17.3 (28)% $39.0 $60.0 (35)% Canadian Medical Cannabis Net Revenue 2 $13.4 $13

  14. Slide 14: Revenue Performance by Form

    REVENUE PERFORMANCE BY FORM vs. (in millions of Canadian dollars, unaudited ) Q1 FY2023 Q1 FY2022 Q1FY2022 Canadian Recreational Cannabis Dry Bud1,2 $38.6 $66.0 (42%) Oils and Softgels1,2 $5.2 $5.7 (9%) Beverages, Edibles, Topicals, andVapes1,2 $7.4 $9.1 (19)% Other Revenue Adjustments2 ($0.6) ($3.0

  15. Slide 15: Gross Margin Performance

    Gross Margin performance Quarterly Gross Margin Trend Drivers of Q1 FY2023 Gross Margin Performance (-) Year-over-year decrease in net revenue and continued price compression Reported Gross Margins Adjusted Gross Margins and under-absorption of fixed costs in the Canadian recreational business (-) B

  16. Slide 16: Operating Expense Trend

    OpeRATING EXPENSE Trend OpEx as a Percentage of Net Sales Quarterly Operating Expense Trend (C$ in 000s) (Q1 FY2022 vs. Q1 FY2023) 160,000 Total OpEx Total OpEx Ex-SBC 60% Q1 FY 2022 Q1 FY 2023 140,000 50% 120,000 40% 100,000 80,000 30% 60,000 20% 40,000 10% 20,000 0 0% Q1 FY2022 Q2 FY2022 Q3 FY2022

  17. Slide 17: Adjusted EBITDA and Free Cash Flow

    ADJUSTED EBITDA AND FREE CASH FLOW Adjusted EBITDA Trend (C$ in 000s) Free Cash Flow Trend (C$ in 000s) Q1 FY2022 Q2 FY2022 Q3 FY2022 Q4 FY2022 Q1 FY2023 Q1 FY2022 Q2 FY2022 Q3 FY2022 Q4 FY2022 Q1 FY2023 $0 $0 -$20,000 -$20,000 -$40,000 -$40,000 -$60,000 -$60,000 -$80,000 -$80,000 -$100,000 -$100,00

  18. Slide 18: Appendix

    Appendix 18

  19. Slide 19: Adjusted Gross Margin (Non-GAAP) Reconciliation

    ADJUSTED GROSS MARGIN 1 (NON-GAAP) RECONCILIATION 19

  20. Slide 20: Adjusted EBITDA (Non-GAAP) Reconciliation

    ADJUSTED EBITDA 1 (NON-GAAP) RECONCILIATION 20

  21. Slide 21: Free Cash Flow (Non-GAAP) Reconciliation

    FREE CASH FLOW 1 (NON-GAAP) RECONCILIATION 21

  22. Slide 22: Thank You

    Thank you 22

Canopy Growth — Q1 FY2023 Earnings Presentation on 6ix